14 February 2013 Use of multiphoton tomography and fluorescence lifetime imaging to investigate skin pigmentation in vivo
Author Affiliations +
Abstract
There is a growing body of literature showing the usefulness of multiphoton tomography (MPT) and fluorescence lifetime imaging for in situ characterization of skin constituents and the ensuing development of noninvasive diagnostic tools against skin diseases. Melanin and pigmentation-associated skin cancers constitute some of the major applications. We show that MPT and fluorescence lifetime imaging can be used to measure changes in cutaneous melanin concentration and that these can be related to the visible skin color. Melanin in the skin of African, Indian, Caucasian, and Asian volunteers is detected on the basis of its emission wavelength and fluorescence lifetimes in solution and in a melanocyte-keratinocyte cell culture. Fluorescence intensity is used to characterize the melanin content and distribution as a function of skin type and depth into the skin (stratum granulosum and stratum basale). The measured fluorescence intensities in given skin types agree with melanin amounts reported by others using biopsies. Our results suggest that spatial distribution of melanin in skin can be studied using MPT and fluorescence lifetime imaging, but further studies are needed to ascertain that the method can resolve melanin amount in smaller depth intervals.
© 2013 Society of Photo-Optical Instrumentation Engineers (SPIE)
Yuri Dancik, Amandine Favre, Chong Jin Loy, Andrei V. Zvyagin, Michael S. Roberts, "Use of multiphoton tomography and fluorescence lifetime imaging to investigate skin pigmentation in vivo," Journal of Biomedical Optics 18(2), 026022 (14 February 2013). https://doi.org/10.1117/1.JBO.18.2.026022 . Submission:
JOURNAL ARTICLE
14 PAGES


SHARE
Back to Top